NDC 0143-9979-90 - Cefuroxime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9979
- Requested NDC
- 0143-9979-90
- Package NDCs from labels
- 0143-9979-90, 0143-9979-22
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2020-04-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefuroxime - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2020-04-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9979-22 | Cefuroxime | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 6 | |
| 0143-9979-90 | Cefuroxime | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9979-22 | EA - Each | 0143-9979 | a1fcd696-e15a-4f81-a5bf-40c30559b012 | 1 | 2012-07-24 |
| 0143-9979-90 | EA - Each | 0143-9979 | 6d2f557c-3f5b-4595-8c2d-db6f5bbc3318 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFUROXIME SODIUM | ACTIVE INGREDIENT | R8A7M9MY61 | CEFUROXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| CEFUROXIME | ACTIVE MOIETY | O1R9FJ93ED | CEFUROXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefuroxime sodium | CEFUROXIME SODIUM | Sagent Pharmaceuticals | 0a145288-733a-4966-b7ae-dc96eb103d8c | 2025-03-27 | Warnings, Adverse reactions | 1665444 1665449 R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 79f5cf6f-a5e2-49a2-9704-fa1bd21338c3 | 2022-02-16 | Warnings, Adverse reactions | R8A7M9MY61 |
| Cefuroxime and Dextrose | CEFUROXIME AND DEXTROSE | B. Braun Medical Inc. | 07170ee3-1a24-424f-a2a2-00bc92e98f85 | 2020-12-05 | Warnings, Adverse reactions | 1665444 1665449 R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 65daa2aa-cc4a-4eba-b7dc-7a151806865a | 2020-04-14 | Warnings, Adverse reactions | R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 703cc338-c0b6-4a02-b8db-c27aeff181df | 2020-04-08 | Warnings, Adverse reactions | ANDA065048 0143-9979-22 0143-9979-90 0143-9977-22 0143-9977-90 0143-9977 0143-9979 00143997990 1665444 1665449 6341f645-bd5f-4d4f-a532-2c0740ab95f5 703cc338-c0b6-4a02-b8db-c27aeff181df R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 19902965-d2d6-433f-982d-0095014df4e8 | 2018-09-27 | Warnings, Adverse reactions | ANDA065048 1665444 1665449 R8A7M9MY61 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.